Super Manthan Pharmaceuticals Private Limited

Super Manthan Pharmaceuticals Private Limited - paper in Ghaziabad, Uttar Pradesh, India. Directors, charges & compliance details.
CIN U21001UP2023PTC184208 Incorporated 19 June 2023 ROC Kanpur HQ Ghaziabad, Uttar Pradesh, India
Active Private Limited Company paper
Revenue · FY 2025
₹8.2 Lakh
Latest filing
Net profit · FY 2025
₹4,900
Net margin 0.6%
EBITDA · FY 2025
₹6,630
EBITDA margin 0.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Super Manthan Pharmaceuticals Private Limited

Data last updated:

Super Manthan Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 19 June 2023.

The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U21001UP2023PTC184208.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Mahendra Singh and Rajwala.

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 5 Green Park Colony Chipyana Buzurg, Ghaziabad, Uttar Pradesh, India – 201009.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.2 Lakh. For the same year it recorded a net profit of ₹4,900 (net margin 0.6%) and EBITDA of ₹6,630 (EBITDA margin 0.8%).

Company details

CIN U21001UP2023PTC184208
Registration Number 184208
Incorporation Date 19 June 2023
ROC Kanpur
Listing Status Unlisted
Company Status Active

Contact details

Super Manthan Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh.

  • Registered Address
    5 Green Park Colony Chipyana Buzurg, Ghaziabad, Uttar Pradesh, India – 201009
  • Industry
    Paper, Paper & Paper Products, Manufacturing
Comprehensive company report
Super Manthan Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Super Manthan Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Super Manthan Pharmaceuticals Private Limited, buy the company report.

Financials of Super Manthan Pharmaceuticals Private Limited

FY 2025 filings available

Super Manthan Pharmaceuticals Private Limited reported revenue of ₹8.2 Lakh for FY 2025.

Revenue · FY 2025
₹8.2 Lakh
Net profit · FY 2025
₹4,900 margin 0.6%
EBITDA · FY 2025
₹6,630 margin 0.8%

Financial Statement Summary

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6,630
Profit Before Tax
Tax Expense
Net Profit (PAT)₹4,900
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin0.8%
Net Profit Margin0.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Super Manthan Pharmaceuticals Private Limited, buy the company report.

Board of directors of Super Manthan Pharmaceuticals Private Limited

Super Manthan Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Mahendra SinghDirector19 Jun 20233 Years 4 MonthsCurrent
RajwalaDirector19 Jun 20233 Years 4 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Super Manthan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Super Manthan Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Super Manthan Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Mahendra Singh was appointed as Director on 19 Jun 2023.

AGM
Super Manthan Pharmaceuticals Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Super Manthan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Appointed
Mahendra Singh was appointed as Director.
Appointed
Rajwala was appointed as Director.
Incorporation
19 Jun 2023
Super Manthan Pharmaceuticals Private Limited was registered on 19 Jun 2023 with Roc Kanpur & aged 3 years 4 months as per MCA records.

Frequently asked questions

Super Manthan Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in paper and paper products, within the paper industry. It was incorporated on 19 June 2023 (3+ years old) and is registered under CIN U21001UP2023PTC184208.

Super Manthan Pharmaceuticals has 2 current directors:

The latest financial statements of Super Manthan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2024 are in the company report.

The CIN (Corporate Identification Number) of Super Manthan Pharmaceuticals is U21001UP2023PTC184208. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Super Manthan Pharmaceuticals was incorporated on 19 June 2023, making it 3+ years old. It is registered with the Registrar of Companies, Kanpur.

Mahendra Singh was appointed as Director on 19 Jun 2023. Rajwala was appointed as Director on 19 Jun 2023.

The registered office of Super Manthan Pharmaceuticals is at 5 Green Park Colony Chipyana Buzurg, Ghaziabad, Uttar Pradesh, India – 201009.

Super Manthan Pharmaceuticals operates in the paper industry, in the paper and paper products segment.

Super Manthan Pharmaceuticals can be reached at its registered office: 5 Green Park Colony Chipyana Buzurg, Ghaziabad, Uttar Pradesh, India – 201009.

Super Manthan Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Kanpur.